Open Label Multi-center Pilot Phase I/II Non-controlled Clinical Trial to Assess Safety and Efficieecy of the Lenalidomide and Dexamethasone Association in Patients With Chronic Relapse or Treatment Resistant Lymphatic Leukemia Following Treatment Containing Fludarabine
Latest Information Update: 16 Oct 2015
At a glance
- Drugs Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions
Most Recent Events
- 11 Feb 2011 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 03 Dec 2010 New trial record